logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Cliniques universitaires Saint-Luc (UCLouvain)

+3227641111
ilse.vanelewijck@saintluc.uclouvain.be
Source: Site record.
http://www.saintluc.be

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Cliniques universitaires Saint-Luc is a premier non-profit academic hospital in Belgium and the largest medical facility in the Brussels-Capital Region. Affiliated with UCLouvain (Université catholique de Louvain), this major teaching institution features over 900 beds and employs approximately 6,000 healthcare professionals. Positioned on the UCLouvain Brussels Woluwe campus, it serves as an international reference center specializing in complex, serious, and rare pathologies, including oncology, pediatric liver transplants, and metabolic disorders. Fully accredited by the AAHRPP for its cutting-edge biomedical research and clinical trials, the hospital blends state-of-the-art medical technology—such as the Da Vinci 5 surgical robot—with highly multilingual care delivered in French, English, Dutch, and several other languages.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Trial-derived.
477Total Trials
Source: Trial-derived.
122Recruiting Trials
Source: Trial-derived.
236Active Trials
Source: Trial-derived.
178Completed Trials
Source: Trial-derived.
585Unique Conditions
Source: Trial-derived.
323Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (16)Source: Trial-derived. Prostate Cancer (10)Source: Trial-derived. Idiopathic Pulmonary Fibrosis (8)Source: Trial-derived. Melanoma (8)Source: Trial-derived. Metastatic Breast Cancer (8)Source: Trial-derived. Multiple Myeloma (7)Source: Trial-derived. Ovarian Cancer (7)Source: Trial-derived. Stroke (7)

Sponsors

Source: Trial-derived. Cliniques universitaires Saint-Luc- Université Catholique de Louvain (121)Source: Trial-derived. Boehringer Ingelheim (28)Source: Trial-derived. Merck Sharp & Dohme LLC (28)Source: Trial-derived. Eli Lilly and Company (26)Source: Trial-derived. Université Catholique de Louvain (22)Source: Trial-derived. European Organisation for Research and Treatment of Cancer - EORTC (17)Source: Trial-derived. Pfizer (16)Source: Trial-derived. Daiichi Sankyo (13)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. Spirometry
Source: AI-inferred. MRI
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. X-Ray

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Sequencing / genomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Liver biopsy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Radiation therapy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. Bone marrow cytology
Source: AI-inferred. EGFR mutation testing
Source: AI-inferred. Electronic patient-reported outcome collection
Source: AI-inferred. Enhanced liver fibrosis testing
Source: AI-inferred. HIV-1 tropism testing
Source: AI-inferred. Immunohistochemistry (IHC) biomarker testing
Source: AI-inferred. Left ventricular ejection fraction assessment